SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
01-Apr-24 7:16 PM View: | Nabi Biopharmaceuticals (VXRT) | 28-Mar-24 | Payment of Exercise | 3,902 | $1.30 | $5,072.60 | (< 1%) 420.12K to 416.22K | |
20-Mar-24 8:12 PM View: | Nabi Biopharmaceuticals (VXRT) | 18-Mar-24 | Grant | 90,000 | -- | -- | 27% 330.12K to 420.12K | |
20-Mar-24 8:12 PM View: | Nabi Biopharmaceuticals (VXRT) | 02-Feb-24 | Payment of Exercise | 9,220 | $1.20 | $11,064.00 | (3%) 339.34K to 330.12K | |
20-Mar-24 8:12 PM View: | Nabi Biopharmaceuticals (VXRT) | 08-Dec-23 | Payment of Exercise | 34,288 | $0.71 | $24,344.50 | (9%) 373.63K to 339.34K | |
20-Mar-24 8:12 PM View: | Nabi Biopharmaceuticals (VXRT) | 28-Mar-23 | Payment of Exercise | 3,683 | $0.75 | $2,762.25 | (< 1%) 377.31K to 373.63K | |
21-Mar-23 7:54 PM View: | Nabi Biopharmaceuticals (VXRT) | 17-Mar-23 | Grant | 189,157 | -- | -- | 101% 188.16K to 377.31K | |
25-Apr-22 4:40 PM View: | Nabi Biopharmaceuticals (VXRT) | 22-Apr-22 | Option Exercise | 40,000 | $0.77 | $30,800.00 | 27% 148.16K to 188.16K | |
30-Mar-22 9:19 PM View: | Nabi Biopharmaceuticals (VXRT) | 28-Mar-22 | Grant | 43,750 | -- | -- | 42% 104.41K to 148.16K | |
11-Aug-21 6:53 PM View: | Nabi Biopharmaceuticals (VXRT) | 10-Aug-21 | Market Sale (Planned) | 4,172 | $10.20 | $42,554.40 | (4%) 114.41K to 110.23K | 9% |
11-Aug-21 6:53 PM View: | Nabi Biopharmaceuticals (VXRT) | 10-Aug-21 | Market Sale (Planned) | 5,828 | $10.20 | $59,445.60 | (5%) 110.23K to 104.41K | 9% |
19-Mar-21 5:04 PM View: | Nabi Biopharmaceuticals (VXRT) | 16-Mar-21 | Option Exercise | 1,006 | $6.49 | $6,528.94 | < 1% 113.4K to 114.41K | 2% |
14-Aug-20 4:21 PM View: | Nabi Biopharmaceuticals (VXRT) | 13-Aug-20 | Option Exercise | 4,026 | $6.49 | $26,128.70 | 4% 109.37K to 113.4K | |
12-Apr-19 6:04 PM View: | Nabi Biopharmaceuticals (VXRT) | 11-Apr-19 | Purchase | 27,273 | $1.10 | $30,000.30 | 33% 82.1K to 109.37K | |
14-Mar-18 9:11 PM View: | Nabi Biopharmaceuticals (VXRT) | 12-Mar-18 | Option Exercise | 2,013 | $6.49 | $13,064.40 | 3% 80.09K to 82.1K | 3% |
15-Feb-18 8:33 PM View: | Nabi Biopharmaceuticals (VXRT) | 13-Feb-18 | Grant | 45,640 | -- | -- | 100% 0 to 45.64K | |
15-Feb-18 8:33 PM View: | Nabi Biopharmaceuticals (VXRT) | 13-Feb-18 | Grant | 34,448 | -- | -- | 75% 45.64K to 80.09K |